Impact of Vitamin D Metabolism on Cardiovascular Disease

Kosaku Nitta

.

DOI: 10.4236/ijcm.2011.25087                

Abstract

Vitamin D is a steroid hormone that enables optimal absorption of calcium from the intestine for bone mineralization. Vitamin D receptor is present in many organs, and there has been of interest in potential functions of vitamin D, particularly in cardiovascular disease. Vitamin D deficiency is thought to be associated with an increased risk of cardiovascular disease. The mechanism by which vitamin D might improve the outcome of cardiovascular disease outcomes remains unclear. However, potential hypotheses have been proposed, including that vitamin D improves the outcome by down-regulating the renin-angiotensin-aldosterone system and by direct effects on the heart and vasculature. The estimated worldwide prevalence of vitamin D deficiency of 50% in elderly populations underlines the importance of vitamin D deficiency as a public health issue. The elderly persons have high rates of comorbid conditions, including cardiovascular disease. This article reviews changes in vitamin D level with age, the impact of vitamin D deficiency on agerelated cardiovascular disease, and different treatment options available for vitamin D deficiency in older populations.

Keywords

Vitamin D, Mortality, Cardiovascular Disease, Hypertension, Therapeutic Option

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	K. A. Nibbelink, D. X. Tishkoff, S. D. Hershey, A. Rahman and R. U. Simpson, “1,25(OH)2-Vitamin D3 Actions on Cell Proliferation, Size, Gene Expression, and Receptor Localization, in the HL-1 Cardiac Myocyte,” The Journal of Steroid Biochemistry and Molecular Biology, Vol. 103, No. 3-5, 2007, pp. 533-537. doi:10.1016/j.jsbmb.2006.12.099
[2]	J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan and P. E. Kroeger, “Effects of Vitamin D Analogs on Gene Expression Profiling in Human Coronary Artery Smooth Muscle Cells,” Atherosclerosis, Vol. 186, No. 1, 2006, pp. 20-28. doi:10.1016/j.atherosclerosis.2005.06.046
[3]	J. Merke, P. Milde, S. Lewicka, et al., “Identification and Regulation of 1,25-Dihydroxyvitamin D3 Receptor Activity and Biosynthesis of 1,25-Dihydroxyvitamin D3. Studies in Cultured Bovine Aortic Endothelial Cells and Human Dermal Capillaries,” The Journal of Clinical Investigation, Vol. 83, No. 6, 1099, pp. 1903-1915.
[4]	M. Cozzolino, M. Ketteler and D. Zehnder, “The Vitamin D System: A Crosstalk between the Heart and Kidney,” European Journal of Heart Failure, Vol. 12, No. 10, 2010, pp. 1031-1041. doi:10.1093/eurjhf/hfq112
[5]	J. L. Anderson, H. T. May, B. D. Horne, et al., “ Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Health Care Population,” The American Journal of Cardiology, Vol. 106, No. 7, 2010, pp. 963-968. doi:10.1016/j.amjcard.2010.05.027
[6]	T. J. Wang, M. J. Pencina, S. L. Booth, et al., “Vitamin D Deficiency and Risk of Cardiovascular Disease,” Circulation, Vol. 117, No. 4, 2008, pp. 503-511. doi:10.1161/CIRCULATIONAHA.107.706127
[7]	M. F. Holick, “Vitamin D Deficiency”, The New England Journal of Medicine, Vol. 357, No. 3, 2007, pp. 266-281. doi:10.1056/NEJMra070553
[8]	R. P. Heaney, “The Vitamin D Requirement in Health and Disease”, The Journal of Steroid Biochemistry and Molecular Biology, Vol. 97, No. 1-2, 2005, pp. 13-19. doi:10.1016/j.jsbmb.2005.06.020
[9]	WHO Scientific Group on the Prevention and Management of Osteoporosis, “Prevention and Management of Osteoporosis: Report of a WHO Scientific Group,” World Health Organization, Geneva, 2003.
[10]	M. F. Holick, E. S. Siris, N. Binkley, et al., “Prevalence of Vitamin D Inadequacy among North American Post Menopausal Women Receiving Osteoporosis Therapy,” The Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 6, 2005, pp. 3215-3224. doi:10.1210/jc.2004-2364
[11]	A. A. Ginde, M. C. Liu and C. A. Camargo Jr., “Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004,” Archives of Internal Medicine, Vol. 169, No. 6, 2009, pp. 626-632. doi:10.1001/archinternmed.2008.604
[12]	C. Oudshoorn, T. J. van der Cammen, M. E. McMurdo, J. P. van Leeuwen and E. M. Colin, “Ageing and Vitamin D Deficiency: Effects on Calcium Homeostasis and Considerations for Vitamin D Supplementation,” British Journal of Nutrition, Vol. 101, No. 11, 2009, pp. 1597-1606. doi:10.1017/S0007114509338842
[13]	M. F. Holick and T. C. Chen, “Vitamin D Deficiency: A Worldwide Problem with Health Consequences,” The American Journal of Clinical Nutrition, Vol. 87, No. 4, 2008, pp. 1080S-1086S.
[14]	E. Orwoll, C. M. Nielson, L. M. Marshall, et al., “Vitamin D Deficiency in Older Men”, The Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 4, 2009, pp. 1214-1222. doi:10.1210/jc.2008-1784
[15]	D. Maggio, A. Cherubini, F. Lauretani, et al., “25(OH)D Serum Levels Decline with Age Earlier in Women than in Men and Less Efficiently Prevent Compensatory Hyper- parathyroidism in Older Adults,” The Journal of Gerontology. Series A, Biological Sciences and Medical Sciences, Vol. 60, No. 11, 2005, pp. 1414-1419.
[16]	J. Kendrick, G. Targher, G. Smits and M. Chonchol, “25- Hydroxyvitamin D Deficiency is Independently Associated with Cardiovascular Disease in the Third National Health and Nutrition Examination Survey,” Atherosclerosis, Vol. 205, No. 1, 2009, pp. 255-260. doi:10.1016/j.atherosclerosis.2008.10.033
[17]	D. H. Kim, S. Sabour, U. N. Sagar, S. Adams and D. J. Whellan, “Prevalence of Hypovitaminosis D in Cardio- vascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004),” The American Journal of Cardiology, Vol. 102, No. 11, 2008, pp. 1540- 1544. doi:10.1016/j.amjcard.2008.06.067
[18]	R. Scragg, M. Sowers and C. Bell, “Serum 25-Hydroxy- vitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey,” American Journal of Hypertension, Vol. 20, 2007, pp. 713-719. doi:10.1016/j.amjhyper.2007.01.017
[19]	D. Martins, M. Wolf, D. Pan, et al., “Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey,” Archives of Internal Medicine, Vol. 167, No. 11, 2007, pp. 1159-1165. doi:10.1001/archinte.167.11.1159
[20]	M. L. Melamed, P. Muntner, E. D. Michos, et al., “Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, No. 6, 2008, pp. 1179-1185. doi:10.1161/ATVBAHA.108.165886
[21]	S. E. Judd, M. S. Nanes, T. R. Ziegler, P. W. Wilson and V. Tangpricha, “Optimal Vitamin D Status Attenuates the Age-Associated Increase in Systolic Blood Pressure in White Americans: Results from the Third National Health and Nutrition Examination Survey,” The American Journal of Clinical Nutrition, Vol. 87, No. 1, 2008, pp. 136-141.
[22]	B. Hintzpeter, G. B. Mensink, W. Thierfelder, M. J. Müller and C. Scheidt-Nave, “Vitamin D Status and Health Correlates among German Adults,” European Journal of Clinical Nutrition, Vol. 62, No. 9, 2008, pp. 1079-1089. doi:10.1038/sj.ejcn.1602825
[23]	M. B. Snijder, P. Lips, J. C. Seidell, et al., “Vitamin D Status and Parathyroid Hormone Levels in Relation to Blood Pressure: A Population-Based Study in Older Men and Women,” Journal of Internal Medicine, Vol. 261, No. 6, 2007, pp. 558-565. doi:10.1111/j.1365-2796.2007.01778.x
[24]	M. L. Melamed, E. D. Michos, W. Post and B. Astor, “25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population,” Archives of Internal Medicine, Vol. 168, No. 15, 2008, pp. 1629-1637. doi:10.1001/archinte.168.15.1629
[25]	S. Pilz, H. Dobnig, G. Nijpels, et al., “Vitamin D and Mortality in Older Men and Women,” Clinical Endocrinology (Oxf), Vol. 71, No. 5, 2009, pp. 666-672. doi:10.1111/j.1365-2265.2009.03548.x
[26]	A. A. Ginde, R. Scragg, R. S. Schwartz and C. A. Camargo Jr., “Prospective Study of Serum 25-Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-Cause Mortality in Older U.S. Adults,” Journal of the American Geriatrics Society, Vol. 57, No. 9, 2009, pp. 1595-1603. doi:10.1111/j.1532-5415.2009.02359.x
[27]	R. D. Semba, D. K. Houston, S. Bandinelli, et al., “Rela- tionship of 25-Hydroxyvitamin D with All-Cause and Cardiovascular Disease Mortality in Older Community-Dwelling Adults,” European Journal of Clinical Nutrition, Vol. 64, No. 2, 2010, pp. 203-209. doi:10.1038/ejcn.2009.140
[28]	Y. C. Li, “Vitamin D Regulation of the Renin-Angio- tensin System,” Journal of Cellular Biochemistry, Vol. 88, No. 2, 2003, pp. 327-331. doi:10.1002/jcb.10343
[29]	S. G. Achinger and J. C. Ayus, “The Role of Vitamin D in Left Ventricular Hypertrophy and Cardiac Function,” Kidney International, Suppl. 95, 2005, pp. S37-S42. doi:10.1111/j.1523-1755.2005.09506.x
[30]	J. H. Lee, O’Keefe, D. Bell, D. D. Hensrud and M. F. Holick, “Vitamin D Deficiency an Important, Common, and Easily Treatable Cardiovascular Risk Factor?” Journal of American College of Cardiology, Vol. 52, No. 24, 2008, pp. 1949-1956. doi:10.1016/j.jacc.2008.08.050
[31]	C. W. Nemerovski, M. P. Dorsch, R. U. Simpson, et al., “Vitamin D and Cardiovascular Disease,” Pharmacotherapy, Vol. 29, No. 6, 2009, pp. 691-670. doi:10.1592/phco.29.6.691
[32]	S. Pilz, W. Marz, B. Wellnitz, et al., “Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography,” The Journal of Clinical Endocrinology and Metabolism, Vol. 93, No. 10, 2008, pp. 3927-3935. doi:10.1210/jc.2008-0784
[33]	P. Autier and S. Gandini, “Vitamin D Supplementation and Total Mortality: A Meta-Analysis of Randomized Controlled Trials,” Archives of Internal Medicine, Vol. 167, No. 16, 2007, pp. 1730-1737. doi:10.1001/archinte.167.16.1730
[34]	H. Dobnig, S. Pilz, H. Scharnagl, et al., “Independent Association of Low Serum 25-Hydroxyvitamin d and 1,25-Dihydroxyvitamin D Levels with All-Cause and Cardiovascular Mortality,” Archives of Internal Medicine, Vol. 168, No. 12, 2008, pp. 1340-1349. doi:10.1001/archinte.168.12.1340
[35]	J. N. Artaza, R. Mehrotra and K. C. Norris, “Vitamin D and Cardiovascular System,” Clinical Journal of American Society of Nephrology, Vol. 4, No. 9, 2009, pp. 1515- 1522. doi:10.2215/CJN.02260409
[36]	M. Visser, D. J. Deeg, M. T. Puts, J. C. Seidell and P. Lips, “Low Serum Concentrations of 25-Hydroxyvitamin D in Older Persons and the Risk of Nursing Home Admission,” The American Journal of Clinical Nutrition, Vol. 84, No. 3, 2006, pp. 616-622.
[37]	E. Giovannucci, Y. Liu, B. W. Hollis and E. B. Rimm, “25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study,” Archives of Internal Medicine, Vol. 168, No. 11, 2008, pp. 1174-1180. doi:10.1001/archinte.168.11.1174
[38]	J. P. Reis, D. von Muhlen, E. D. Michos, et al., “Serum Vitamin D, Parathyroid Hormone Levels, and Carotid Atherosclerosis,” Ahterosclerosis, Vol. 207, No. 2, 2009, pp. 585-590. doi:10.1016/j.atherosclerosis.2009.05.030
[39]	R. Krause, M. Bühring, W. Hopfenmüller, M. F. Holick and A. M. Sharma, “Ultraviolet B and Blood Pressure,” The Lancet, Vol. 352, No. 9129, 1998, pp. 709-710. doi:10.1016/S0140-6736(05)60827-6
[40]	M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall and C. Hansen, “Effects of a Short-Term Vitamin D(3) and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women,” The Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 4, 2001, pp. 1633-1637. doi:10.1210/jc.86.4.1633
[41]	B. Myrup, G. F. Jensen and P. McNair, “Cardiovascular Risk Factors during Estrogennorethindrone and Cholecalciferol Treatment,” Archives of Internal Medicine, Vol. 152, No. 11, 1992, pp. 2265-2268. doi:10.1001/archinte.152.11.2265
[42]	W. H. Pan, C. Y. Wang, L. A. Li, L. S. Kao and S. H. Yeh, “No Significant Effect of Calcium and Vitamin D Supplementation on Blood Pressure and Calcium Metabolism in Elderly Chinese,” Chinese Journal of Physiology, Vol. 36, No. 2, 1993, pp. 85-94.
[43]	R. Scragg, K. T. Khaw and S. Murphy, “Effect of Winter oral Vitamin D3 Supplementation on Cardiovascular Risk Factors in Elderly Adults,” European Journal of Clinical Nutrition, Vol. 49, No. 9, 1995, pp. 640-646.
[44]	K. L. Margolis, R. M. Ray, L. Van Horn, et al., “Effect of Calcium and Citamin D Supplementation on Blood Pressure: The Women’s Health Initiative Randomized Trial,” Hypertension, Vol. 52, No. 5, 2008, pp. 847-855. doi:10.1161/HYPERTENSIONAHA.108.114991
[45]	D. P. Trivedi, R. Doll and K. T. Khaw, “Effect of Four Monthly Oral Vitamin D3 (Cholecalciferol) Supplementation on Fractures and Mortality in Men and Women Living in the Community: Randomized Double Blind Controlled Trial,” British Medical Journal, Vol. 326, No. 7387, 2003, p. 469. doi:10.1136/bmj.326.7387.469
[46]	A. Z. Lacroix, J. Kotchen, G. Anderson, et al., “Calcium plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women’s Health Initiative Calcium-Vitamin D Randomized Controlled Trial,” The Journals of Gerontology. Series A. Biological Sciences and Medical Sciences, Vol. 64, No. 5, 2009, pp. 559-567. doi:10.1093/gerona/glp006
[47]	M. Wolf, A. Shah, O. Gutierrez, et al., “Vitamin D Levels and Early Mortality among Incident Hemodialysis Patients,” Kidney International, Vol. 72, No. 8, 2007, pp. 1004-1013. doi:10.1038/sj.ki.5002451
[48]	L. Wang, J. E. Manson, Y. Song and H. D. Sesso, “Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events,” Annals of Internal Medicine, Vol. 152, No. 5, 2010, pp. 315-323.
[49]	Y. C. Li, J. Kong, M. Wei, Z. F. Chen, S. Q. Liu and L. P. Cao, “1,25-Dihydroxyvitamin D(3) Is a Negative Endocrine Regulator of the Renin-Angiotensin System,” The Journal of Clinical Investigation, Vol. 110, No. 2, 2002, pp. 229-238.
[50]	G. Qiao, J. Kong, M. Uskokovic and Y.C. Li, “Analogs of Lalpha, 25-Dihydroxyvitamin D(3) as Novel Inhibitors of Renin Biosynthesis,” The Journal of Steroid Biochemistry and Molecular Biology, Vol. 96, No. 1, 2005, pp. 59- 66. doi:10.1016/j.jsbmb.2005.02.008
[51]	W. Yuan, W. Pan, J. Kong, et al., “1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter,” The Journal of Biological Chemistry, Vol. 282, No. 41, 2007, pp. 29821-29830. doi:10.1074/jbc.M705495200
[52]	A. Rahman, S. Hershey, S. Ahmed, K. Nibbelink and R. U. Simpson, “Heart Extracellular Matrix Gene Expression Profile in the Vitamin D Receptor Knockout Mice,” The Journal of Steroid Biochemistry and Molecular Biology, Vol. 103, No. 3-5, 2007, pp. 416-419. doi:10.1016/j.jsbmb.2006.12.081
[53]	D. X. Tishkoff, K. A. Nibbelink, K. H. Holmberg, L. Dandu and R. U. Simpson, “Functional Vitamin D Receptor (VDR) in the t-Tubules of Cardiac Myocytes: VDR Knockout Cardiomyocyte Contractility,” Endocrinology, Vol. 149, No. 2, 2008, pp. 558-564. doi:10.1210/en.2007-0805
[54]	R. U. Simpson, S. H. Hershey and K. A. Nibbelink, “Characterization of Heart Size and Blood Pressure in the Vitamin D Receptor Knockout Mouse,” The Journal of Steroid Biochemistry and Molecular Biology, Vol. 103, No. 3-5, 2007, pp. 521-524. doi:10.1016/j.jsbmb.2006.12.098
[55]	J. N. Artaza and K. C. Norris, “Vitamin D Reduces the Expression of Collagen and Key Profibrotic Factors by Inducing an Antifibrotic Phenotype in Mesenchymal Multipotent Cells,” Journal of Endocrinology, Vol. 200, No. 2, 2009, pp. 207-221. doi:10.1677/JOE-08-0241
[56]	S. S. Schleithoff, A. Zittermann, G. Tenderich, H. K. Berthold, P. Stehle and R. Koerfer, “Vitamin D Supplementation Improves Cytokine Profiles in Patients with Congestive Heart Failure: A Double-Blind, Randomized, Placebo-Controlled Trial,” The American Journal of Clinical Nutrition, Vol. 83, No. 4, 2006, pp. 754-759.